333
Views
13
CrossRef citations to date
0
Altmetric
Review

Drug delivery in acute myeloid leukemia

, Dipl. Mol. Med., , Dipl. Biol. & , MD PhD
Pages 653-663 | Published online: 05 Jun 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Hidayat Hussain, Iftikhar Ali, Daijie Wang, Faruck L. Hakkim, Bernhard Westermann, Ishtiaq Ahmed, Ahmed M. Ashour, Amjad Khan, Amjad Hussain, Ivan R. Green & Syed Tasadaque Ali Shah. (2021) Glycyrrhetinic acid: a promising scaffold for the discovery of anticancer agents. Expert Opinion on Drug Discovery 16:12, pages 1497-1516.
Read now
Mascha Binder & Martin Trepel. (2009) Drugs targeting integrins for cancer therapy. Expert Opinion on Drug Discovery 4:3, pages 229-241.
Read now

Articles from other publishers (11)

Yuqian Zhang, Zixuan Sheng, Jing Xiao, Yang Li, Jie Huang, Jinjing Jia, Xiansi Zeng & Li Li. (2023) Advances in the roles of glycyrrhizic acid in cancer therapy. Frontiers in Pharmacology 14.
Crossref
Edvin Tang Gundersen, Jan-Lukas Førde, Benedicte Sjo Tislevoll, Calum Leitch, Gillian Barratt, Bjørn Tore Gjertsen & Lars Herfindal. (2022) Repurposing chlorpromazine for anti-leukaemic therapy by nanoparticle encapsulation. International Journal of Pharmaceutics 612, pages 121296.
Crossref
Jianfeng Guo, Xue Luan, Zhongcheng Cong, Yao Sun, Limei Wang, Sharon L. McKenna, Mary R. Cahill & Caitriona M. O'Driscoll. (2018) The potential for clinical translation of antibody-targeted nanoparticles in the treatment of acute myeloid leukaemia. Journal of Controlled Release 286, pages 154-166.
Crossref
Xitong Su, Lei Wu, Mingming Hu, Wenxiang Dong, Meng Xu & Peng Zhang. (2017) Glycyrrhizic acid: A promising carrier material for anticancer therapy. Biomedicine & Pharmacotherapy 95, pages 670-678.
Crossref
Jiaoyan Ren, Rong Zhang & Joe M. Regenstein. 2017. Nutrient Delivery. Nutrient Delivery 497 534 .
Mohd. Asif Sherwani, Saba Tufail, Aijaz Ahmed Khan & Mohammad Owais. (2015) Dendrimer-PLGA based multifunctional immuno-nanocomposite mediated synchronous and tumor selective delivery of siRNA and cisplatin: potential in treatment of hepatocellular carcinoma. RSC Advances 5:49, pages 39512-39531.
Crossref
Teerapong Yata, Nastasia Nianiaris, Sirirurg Songsivilai & Amin Hajitou. 2014. Gene Therapy of Cancer. Gene Therapy of Cancer 479 490 .
Ruei-Min Lu, Min-Shan Chen, De-Kuan Chang, Chien-Yu Chiu, Wei-Chuan Lin, Shin-Long Yan, Yi-Ping Wang, Yuan-Sung Kuo, Chen-Yun Yeh, Albert Lo & Han-Chung Wu. (2013) Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and Imaging. PLoS ONE 8:6, pages e66128.
Crossref
Carlee E. Ashley, Eric C. Carnes, Genevieve K. Phillips, David Padilla, Paul N. Durfee, Page A. Brown, Tracey N. Hanna, Juewen Liu, Brandy Phillips, Mark B. Carter, Nick J. Carroll, Xingmao Jiang, Darren R. Dunphy, Cheryl L. Willman, Dimiter N. Petsev, Deborah G. Evans, Atul N. Parikh, Bryce Chackerian, Walker Wharton, David S. Peabody & C. Jeffrey Brinker. (2011) The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nature Materials 10:5, pages 389-397.
Crossref
Brice Korkmaz, Marshall S. Horwitz, Dieter E. Jenne & Francis Gauthier. (2010) Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases. Pharmacological Reviews 62:4, pages 726-759.
Crossref
Stefan Michelfelder & Martin Trepel. 2009. Tissue-Specific Vascular Endothelial Signals and Vector Targeting, Part A. Tissue-Specific Vascular Endothelial Signals and Vector Targeting, Part A 29 60 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.